- Say D, Crawford N, McNab S, et al. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc Health. 2021;5:e22–e23. doi:https://doi.org/10.1016/S2352-4642(21)00124-3.
- Ludvigsson JF. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr. 2021;110:914–921. doi:https://doi.org/10.1111/apa.15673.
- Denina M, Pruccoli G, Scolfaro C, et al. Sequelae of COVID-19 in hospitalized children: a 4-months follow-up. Pediatr Infect Dis J. 2020;39:e458–e459. doi:https://doi.org/10.1097/INF.0000000000002937.
- Schumann JA, Sood T, Parente JJ. Costochondritis. In: StatPearls. Treasure Island, FL: StatPearls; 2021.
- Reddy SR, Singh HR. Chest pain in children and adolescents. Pediatr Rev. 2010;31:e1–e9. doi:https://doi.org/10.1542/pir.31-1-e1.
- Friedman KG, Alexander ME. Chest pain and syncope in children: a practical approach to the diagnosis of cardiac disease. J Pediatr. 2013;163:896–901. doi:https://doi.org/10.1016/j.jpeds.2013.05.001.
- Gesuete V, Fregolent D, Contorno S, et al. Follow-up study of patients admitted to the pediatric emergency department for chest pain. Eur J Pediatr. 2020;179:303–308. doi:https://doi.org/10.1007/s00431-019-03495-5.
- Sadiq NM, Robinson KJ, Terrell JM. Colchicine. In: StatPearls. Treasure Island, FL: StatPearls; 2021.
- Karatza E, Ismailos G, Karalis V. Colchicine for the treatment of COVID-19 patients: efficacy, safety, and model informed dosage regimens. Xenobiotica. 2021;51:643–656. doi:https://doi.org/10.1080/00498254.2021.1909782.
- Schlesinger N, Firestein BL, Brunetti L. Colchicine in COVID-19: an old drug, new use. Curr Pharmacol Rep. 2020;1–9. doi:https://doi.org/10.1007/s40495-020-00225-6.
- Vitiello A, Ferrara F. Colchicine and SARS-CoV-2: management of the hyperinflammatory state. Respir Med. 2021;178:106322. doi:https://doi.org/10.1016/j.rmed.2021.106322.
- Reyes AZ, Hu KA, Teperman J, et al. Anti-inflammatory therapy for COVID-19 infection: the case for colchicine. Ann Rheum Dis. 2021;80:550–557. doi:https://doi.org/10.1136/annrheumdis-2020-219174.
- Misra DP, Gasparyan AY, Zimba O. Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates. Rheumatol Int. 2020;40:1741–1751. doi:https://doi.org/10.1007/s00296-020-04694-2.
Severe post-COVID-19 costochondritis in children
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.